questionsmedicales.fr
Acides nucléiques, nucléotides et nucléosides
Acides nucléiques
ADN
ADN bactérien
ADN bactérien : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ADN bactérien : Questions médicales les plus fréquentes",
"headline": "ADN bactérien : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ADN bactérien : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ADN bactérien"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "ADN",
"url": "https://questionsmedicales.fr/mesh/D004247",
"about": {
"@type": "MedicalCondition",
"name": "ADN",
"code": {
"@type": "MedicalCode",
"code": "D004247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.308"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "ADN bactérien",
"alternateName": "DNA, Bacterial",
"code": {
"@type": "MedicalCode",
"code": "D004269",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lyle A Simmons",
"url": "https://questionsmedicales.fr/author/Lyle%20A%20Simmons",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI, USA. lasimm@umich.edu."
}
},
{
"@type": "Person",
"name": "Marc Joyeux",
"url": "https://questionsmedicales.fr/author/Marc%20Joyeux",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire Interdisciplinaire de Physique, CNRS and Université Grenoble Alpes, Grenoble, France. Electronic address: marc.joyeux@univ-grenoble-alpes.fr."
}
},
{
"@type": "Person",
"name": "George Tetz",
"url": "https://questionsmedicales.fr/author/George%20Tetz",
"affiliation": {
"@type": "Organization",
"name": "Human Microbiology Institute, New York, NY, 10013, USA. g.tetz@hmi-us.com."
}
},
{
"@type": "Person",
"name": "Victor Tetz",
"url": "https://questionsmedicales.fr/author/Victor%20Tetz",
"affiliation": {
"@type": "Organization",
"name": "Human Microbiology Institute, New York, NY, 10013, USA."
}
},
{
"@type": "Person",
"name": "David N Fredricks",
"url": "https://questionsmedicales.fr/author/David%20N%20Fredricks",
"affiliation": {
"@type": "Organization",
"name": "Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United states of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.",
"datePublished": "2023-01-13",
"url": "https://questionsmedicales.fr/article/36651430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/acb371205"
}
},
{
"@type": "ScholarlyArticle",
"name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36253300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clgc.2022.09.007"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.",
"datePublished": "2024-10-20",
"url": "https://questionsmedicales.fr/article/39428439",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-76355-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.",
"datePublished": "2023-05-26",
"url": "https://questionsmedicales.fr/article/37271051",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmpb.2023.107624"
}
},
{
"@type": "ScholarlyArticle",
"name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.",
"datePublished": "2023-03-14",
"url": "https://questionsmedicales.fr/article/36917412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11255-023-03531-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ADN",
"item": "https://questionsmedicales.fr/mesh/D004247"
},
{
"@type": "ListItem",
"position": 5,
"name": "ADN bactérien",
"item": "https://questionsmedicales.fr/mesh/D004269"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ADN bactérien - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ADN bactérien",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ADN bactérien",
"description": "Comment détecter l'ADN bactérien dans un échantillon ?\nQuels tests sont utilisés pour identifier des bactéries spécifiques ?\nQuelles méthodes permettent d'analyser la diversité de l'ADN bactérien ?\nComment l'ADN bactérien est-il extrait pour analyse ?\nQuels sont les signes d'infection bactérienne dans un test ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ADN bactérien",
"description": "Quels symptômes indiquent une infection bactérienne ?\nComment l'ADN bactérien influence-t-il les symptômes ?\nLes symptômes varient-ils selon le type de bactérie ?\nQuels symptômes sont associés aux infections urinaires bactériennes ?\nComment reconnaître une infection bactérienne grave ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ADN bactérien",
"description": "Quelles mesures préventives réduisent les infections bactériennes ?\nComment la vaccination aide-t-elle à prévenir les infections ?\nPourquoi est-il important de compléter les traitements antibiotiques ?\nQuels rôles jouent l'hygiène personnelle dans la prévention ?\nComment éviter les infections lors de procédures médicales ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ADN bactérien",
"description": "Quels antibiotiques ciblent l'ADN bactérien ?\nComment les antibiotiques agissent-ils sur l'ADN bactérien ?\nQuels traitements sont utilisés pour les infections résistantes ?\nLes traitements varient-ils selon le type de bactérie ?\nComment la résistance aux antibiotiques affecte-t-elle le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ADN bactérien",
"description": "Quelles complications peuvent survenir avec une infection bactérienne ?\nComment l'ADN bactérien peut-il causer des maladies chroniques ?\nQuels sont les risques d'une infection non traitée ?\nComment les infections bactériennes affectent-elles le système immunitaire ?\nQuelles complications peuvent résulter d'une résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ADN bactérien",
"description": "Quels facteurs augmentent le risque d'infections bactériennes ?\nComment l'âge influence-t-il le risque d'infection ?\nQuel rôle joue l'hygiène dans le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nComment les conditions de vie affectent-elles le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D004269?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecter l'ADN bactérien dans un échantillon ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ADN bactérien peut être détecté par PCR ou séquençage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier des bactéries spécifiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de culture et les méthodes moléculaires comme la PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles méthodes permettent d'analyser la diversité de l'ADN bactérien ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le séquençage de nouvelle génération et l'analyse phylogénétique sont courants."
}
},
{
"@type": "Question",
"name": "Comment l'ADN bactérien est-il extrait pour analyse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'extraction se fait par lyse cellulaire suivie de purification de l'ADN."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'infection bactérienne dans un test ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La présence d'ADN bactérien dans un échantillon indique une infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection bactérienne ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, inflammation et fatigue sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment l'ADN bactérien influence-t-il les symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ADN bactérien peut provoquer des réponses immunitaires entraînant des symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de bactérie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de bactérie peut provoquer des symptômes différents."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections urinaires bactériennes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Brûlures, besoin fréquent d'uriner et douleurs lombaires sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une infection bactérienne grave ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes sévères comme la septicémie nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives réduisent les infections bactériennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hygiène, la vaccination et l'utilisation prudente des antibiotiques sont essentielles."
}
},
{
"@type": "Question",
"name": "Comment la vaccination aide-t-elle à prévenir les infections ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins stimulent le système immunitaire pour combattre des bactéries spécifiques."
}
},
{
"@type": "Question",
"name": "Pourquoi est-il important de compléter les traitements antibiotiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Compléter le traitement prévient la résistance et assure l'élimination des bactéries."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent l'hygiène personnelle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bon lavage des mains et une hygiène corporelle réduisent la transmission bactérienne."
}
},
{
"@type": "Question",
"name": "Comment éviter les infections lors de procédures médicales ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles d'asepsie stricts et l'utilisation d'antibiotiques prophylactiques sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quels antibiotiques ciblent l'ADN bactérien ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fluoroquinolones et les rifamycines inhibent la synthèse de l'ADN bactérien."
}
},
{
"@type": "Question",
"name": "Comment les antibiotiques agissent-ils sur l'ADN bactérien ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils interfèrent avec la réplication et la réparation de l'ADN bactérien."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour les infections résistantes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques de dernier recours ou des thérapies combinées sont souvent nécessaires."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de bactérie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choix des antibiotiques dépend du type de bactérie et de sa sensibilité."
}
},
{
"@type": "Question",
"name": "Comment la résistance aux antibiotiques affecte-t-elle le traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance rend certains antibiotiques inefficaces, nécessitant des alternatives."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une infection bactérienne ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'abcès, la septicémie ou des dommages organiques peuvent se produire."
}
},
{
"@type": "Question",
"name": "Comment l'ADN bactérien peut-il causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines bactéries peuvent persister et provoquer des maladies chroniques comme la bronchite."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une infection non traitée ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection non traitée peut entraîner des complications graves, y compris la mort."
}
},
{
"@type": "Question",
"name": "Comment les infections bactériennes affectent-elles le système immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent affaiblir le système immunitaire, rendant l'organisme plus vulnérable."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une résistance aux antibiotiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance peut mener à des infections persistantes et à des traitements prolongés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infections bactériennes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le diabète et l'hospitalisation augmentent le risque d'infections."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées et les jeunes enfants sont plus susceptibles aux infections bactériennes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hygiène dans le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise hygiène augmente le risque de transmission et d'infections bactériennes."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le VIH ou le diabète augmentent la vulnérabilité aux infections."
}
},
{
"@type": "Question",
"name": "Comment les conditions de vie affectent-elles le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conditions de vie insalubres favorisent la propagation des bactéries et des infections."
}
}
]
}
]
}
Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat...
Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus....
Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ...
There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....
In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals....
This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ...
It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high...
As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...
In recent observational studies, a potential link between prostatitis and prostate cancer (PCa) has been hinted at, yet the causality remains ambiguous. In our endeavor to scrutinize the conceivable c...
With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di...
We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ...
An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve...
This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...
To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n...
The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit...
In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ...
A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...
Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o...
PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u...
More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ...
Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....
Prostate-specific membrane antigen (PSMA) hybrid imaging is a promising new technique gaining importance in the field of prostate cancer (PCa) diagnosis and treatment planning. By combining PSMA radio...
Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga...
Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu...
Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114...
The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...
Purpose: Determine the time-dependent magnitude of intrafraction prostate displacement and a cutoff for the tracking decision. Methods: Nine patients with localized prostate cancer were treated with u...
Apart from other risk factors, chronic inflammation is also associated with the onset of Prostate Cancer (PCa), wherein pathogen infection and tissue microbiome dysbiosis are known to play a major rol...